Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Florida’s KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Florida’s KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 19 2024

Full Issue

Psychedelic Mushroom Candies Include Illegal Hallucinogens, Testing Finds

Virginia consumers, including a 3-year-old child, have been falling ill after ingesting products that contain substances that they should not. Also in the news: MDMA clinical trials and cannabis sales.

A new study published Thursday finds that several mushroom candies, which are widely promoted as containing legal psychedelic ingredients, actually contain illegal hallucinogens. The study sampled products sold in gas stations and smoke shops near Charlottesville, Va. It identified the Schedule I drug psilocin in mushroom candies sold under the brand names Diamond Shruumz and Wonderland Legal Psychedelics. A product sold under the brand Urb contained both psilocybin and psilocin. (Florko, 7/18)

People eating some of the now-recalled Diamond Shruumz brand candies may also have been getting a dose of an illegal substance from magic mushrooms, testing by a Virginia poison control center has confirmed. The Blue Ridge Poison Center at the University of Virginia says they found psilocin among the undisclosed substances mixed into Diamond Shruumz gummies. (Tin, 7/18)

Five people in Virginia, including a three-year-old child, fell ill after consuming the gummies, according to a new Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report. ... Researchers also found other harmful ingredients in the gummies, including the hallucinogen psilocin, as well as caffeine, ephedrine, and kratom. (Thomson, 7/18)

Also —

At a contentious advisory committee meeting in June, the Food and Drug Administration announced it was investigating allegations of data suppression and misconduct in clinical trials of MDMA-assisted therapy. (Goldhill, 7/19)

A federal judge on Thursday refused to halt New York City's crackdown on unlicensed sellers of cannabis, citing public safety concerns. U.S. District Judge Paul Oetken in Manhattan said 27 cannabis sellers whose businesses were shut down were unlikely to succeed on their claim that the closures violated their due process rights under the U.S. Constitution's 14th Amendment. A lawyer for the sellers did not immediately respond to requests for comment. (Stempel, 7/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ